XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 08, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Trading Symbol ADGI  
Entity Registrant Name Adagio Therapeutics, Inc.  
Entity Central Index Key 0001832038  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   108,830,525
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity File Number 001-40703  
Entity Tax Identification Number 85-1403134  
Entity Address, Address Line One 1601 Trapelo Road  
Entity Address, Address Line Two Suite 178  
Entity Address, City or Town Waltham  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02451  
City Area Code 781  
Local Phone Number 819-0080  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Security Exchange Name NASDAQ  
Entity Incorporation, State or Country Code DE  
Document Quarterly Report true  
Document Transition Report false